![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 21, 13654-13660, 07, 1991
SS Deeb, MC Cheung, RL Peng, AC Wolf, R Stern, JJ Albers and RH Knopp
Epidemiologic and genetic data suggest an inverse relationship between
plasma high density lipoprotein (HDL) cholesterol and the incidence of
premature coronary artery disease. Some of the defects leading to low
levels of HDL may be a consequence of mutations in the genes coding for HDL
apolipoproteins A-I and A-II or for enzymes that modify these particles. A
proband with plasma apoA-I and HDL cholesterol that are below 15% of normal
levels and with marked bilateral arcus senilis was shown to be heterozygous
for a 45-base pair deletion in exon four of the apoA-I gene. This most
likely represents a de novo mutation since neither parent carries the
mutant allele. The protein product of this allele is predicted to be
missing 15 (Glu146-Arg160) of the 22 amino acids comprising the third
amphipathic helical domain. The HDL of the proband and his family were
studied. Using anti-A-I and anti-A-II immunosorbents we found three
populations of HDL particles in the proband. One contained both apoA-I and
A-II, Lp(A-I w A-II); one contained apoA-I but no A-II, Lp(A-I w/o A-II);
and the third (an unusual one) contained apoA-II but no A-I. Only Lp(A-I w
A-II) and (A-I w/o A-II) were present in the plasma of the proband's
parents and brother. Analysis of the HDL particles of the proband by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis revealed two protein
bands with a molecular mass differing by 6% in the vicinity of 28 kDa
whereas the HDL particles of the family members exhibited only a single
apoA-I band. The largely dominant effect of this mutant allele (designated
apoA-ISeattle) on HDL levels suggests that HDL particles containing any
number of mutant apoA-I polypeptides are catabolized rapidly.
A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins
Department of Medicine, University of Washington School of Medicine, Seattle.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency J. Lipid Res., February 1, 2008; 49(2): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bhat, M. Zabalawi, M. C. Willingham, G. S. Shelness, M. J. Thomas, and M. G. Sorci-Thomas Quality control in the apoA-I secretory pathway: deletion of apoA-I helix 6 leads to the formation of cytosolic phospholipid inclusions J. Lipid Res., July 1, 2004; 45(7): 1207 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia J. Lipid Res., January 1, 2002; 43(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tailleux, M. Bouly, G. Luc, G. Castro, J.-M. Caillaud, N. Hennuyer, P. Poulain, J.-C. Fruchart, N. Duverger, and C. Fievet Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2000; 20(11): 2453 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Frank and Y. L. Marcel Apolipoprotein A-I: structure;-function relationships J. Lipid Res., June 1, 2000; 41(6): 853 - 872. [Abstract] [Full Text] |
||||
![]() |
M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holvoet, B. De Geest, S. Van Linthout, M. Lox, S. Danloy, K. Raes, and D. Collen The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase-Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 459 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hammad, S. Stefansson, W. O. Twal, C. J. Drake, P. Fleming, A. Remaley, H. B. Brewer Jr., and W. S. Argraves Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis PNAS, August 31, 1999; 96(18): 10158 - 10163. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Han, J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, et al. A Novel Mutant, ApoA-I Nichinan (Glu235->0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1447 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsunaga, J. Sasaki, H. Han, W. Huang, M. Kugi, T. Koga, S. Ichiki, T. Shinkawa, and K. Arakawa Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 348 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, D. Aiello, H. Pritchard, G. Friel, and K. Zeller Apolipoprotein A-IZavalla (Leu159->Pro) : HDL Cholesterol Deficiency in a Kindred Associated With Premature Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1242 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Eberhart, A. J. Mendez, and M. W. Freeman Decreased Cholesterol Efflux from Fibroblasts of a Patient without Tangier Disease, but with Markedly Reduced High Density Lipoprotein Cholesterol Levels J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 836 - 846. [Abstract] [Full Text] |
||||
![]() |
W. Huang, J. Sasaki, A. Matsunaga, H. Nanimatsu, K. Moriyama, H. Han, M. Kugi, T. Koga, K. Yamaguchi, and K. Arakawa A Novel Homozygous Missense Mutation in the Apo A-I Gene With Apo A-I Deficiency Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 389 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Miettinen, M. Jauhiainen, H. Gylling, S. Ehnholm, A. Palomaki, T. A. Miettinen, and K. Kontula Apolipoprotein A-IFIN (Leu159->Arg) Mutation Affects Lecithin : Cholesterol Acyltransferase Activation and Subclass Distribution of HDL but Not Cholesterol Efflux From Fibroblasts Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3021 - 3032. [Abstract] [Full Text] |
||||
![]() |
M. Laccotripe, S. C. Makrides, A. Jonas, and V. I. Zannis The Carboxyl-terminal Hydrophobic Residues of Apolipoprotein A-I Affect Its Rate of Phospholipid Binding and Its Association with High Density Lipoprotein J. Biol. Chem., July 11, 1997; 272(28): 17511 - 17522. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Miettinen, H. Gylling, T. A. Miettinen, J. Viikari, L. Paulin, and K. Kontula Apolipoprotein A-IFin: Dominantly Inherited Hypoalphalipoproteinemia Due to a Single Base Substitution in the Apolipoprotein A-I Gene Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 83 - 90. [Abstract] [Full Text] |
||||
![]() |
K. Moriyama, J. Sasaki, Y. Takada, A. Matsunaga, J. Fukui, J. J. Albers, and K. Arakawa A Cysteine-Containing Truncated Apo A-I Variant Associated With HDL Deficiency Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1416 - 1423. [Abstract] [Full Text] |
||||
![]() |
P. Holvoet, Z. Zhao, E. Deridder, A. Dhoest, and D. Collen Effects of Deletion of the Carboxyl-terminal Domain of ApoA-I or of Its Substitution with Helices of ApoA-II on in Vitro and in Vivo Lipoprotein Association J. Biol. Chem., August 9, 1996; 271(32): 19395 - 19401. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2157 - 2164. [Abstract] [Full Text] |
||||
![]() |
M. Marcil, B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, and J. Genest Jr Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1015 - 1024. [Abstract] [Full Text] |
||||
![]() |
H. H.-J. Schmidt, A. T. Remaley, J. A. Stonik, R. Ronan, A. Wellmann, F. Thomas, L. A. Zech, H. B. Brewer Jr., and J. M. Hoeg Carboxyl-terminal Domain Truncation Alters Apolipoprotein A-I in Vivo Catabolism J. Biol. Chem., March 10, 1995; 270(10): 5469 - 5475. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chait and S. Kent Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins Science, September 25, 1992; 257(5078): 1885 - 1894. [Abstract] [PDF] |
||||
![]() |
D. C. McManus, B. R. Scott, V. Franklin, D. L. Sparks, and Y. L. Marcel Proteolytic Degradation and Impaired Secretion of an Apolipoprotein A-I Mutant Associated with Dominantly Inherited Hypoalphalipoproteinemia J. Biol. Chem., June 8, 2001; 276(24): 21292 - 21302. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |